Real-world examples.

An illness is considered rare in the EU when fewer than five people per 10,000 suffer from it. An early and correct diagnosis is a common hurdle to the treatment of these so-called “orphan diseases”. The key to success is creating awareness of the respective illness and possible treatments, especially among experts.

What do you do when you belong to an unexciting industry with a shortage of new talent and no one really wants to talk to you?

Innerhalb von knapp sechs Wochen verwandelten STADA und komm.passion ein unscheinbares Büro im Hauptgebäude der STADA Arzneimittel AG in ein hochmodernes TV-Studio. Und streamten am 17. Juni die erste Live-Veranstaltung aus eben diesem Studio.

Generics – this is the name for imitation substances whose active ingredients match already approved medications. How is it possible for a generics manufacturer without any product-side unique selling points to differentiate itself and create an identity of its own that is recognized by expert groups, patients and practitioners alike?

Showing the stories of people who live a life with no compromises despite having a rare blood disease (hemophilia): This was the core idea behind the disease awareness campaign by Swedish Orphan Biovitrum (Sobi). Before the Covid-19 pandemic, “Liberate Life on Tour” visited people across Germany to create awareness through emotional short films about the possibility of a self-determined life in spite of having a chronic illness.

Just about everyone in Germany has come into contact with the mid-sized company ICA Traffic GmbH: 70% of all ticketing systems in Germany’s public transportation are “made by ICA”. The company from Dortmund is definitely a key player in the transport sector. Now the company aims to conquer the highly competitive health sector with its disinfection robot HERO21, and has brought the communications consultants and creative experts at komm.passion on board to help.

komm.passion developed a pan-European communications strategy and partnership model for BELFOR that addresses the diverse services and target groups of the individual countries and builds off of BELFOR’s existing hero theme.

komm.passion is developing a campaign that aims to help people feel alive: With the right treatment, hemophilia patients can go virtually without restrictions in their daily lives. They can lead truly active lives.

The campaign “We Are Sugar” came to life in 2019. Its goal: to show everything sugar beets can do: for the environment, the climate, our groundwater and for rural areas – and why they need to be protected – through clear but also emotional statements from people whose livelihoods depend on the sugar beet.

Insurance corporation R+V Versicherung AG is successful. The company has been growing faster than the market for years now, and numbers among Germany’s top employers. But the market is changing faster and faster. Competitive pressure and customer demands are constantly rising. For this reason, R+V initiated the change strategy “Growth Through Transformation" (GTT) that aims to optimally prepare the insurer to face these challenges. komm.passion is supporting the market leader in the areas of change management and internal change communication throughout the entire campaign.

The energy revolution is multifaceted: Renewable energies, grid expansion, e-mobility and sector coupling. In our campaign “WE HERE IN THE EAST” for enviaM, we explain what’s behind all this.

Tons of informational brochures about psoriasis are available. Usually these are well-intentioned guides for a target group that has the feeling it’s already read it all. But how do you reach people who have been excluded because of their condition, kicked out of public swimming pools, people who stopped informing themselves about the disease and have withdrawn into lives of private isolation?

STADA is one of Europe’s leading providers of generic pharmaceuticals. The company’s main focus is on strong brands with high relevance in consumers’ daily lives – from Ladival sunscreen to megasellers like Grippostad cold medicine or the sleep aid Hoggar Night. This is supported by a highly diversified portfolio as well as by innovative solutions like biosimilars.